Yet, the presence of amyloidosis is not always equivalent to clinically relevant AD neuropathology, which also requires AD tau tangles [207]: Braak III or above for intermediate level of AD neuropathology changes, Braak V or VI for high level. Here, MAPT is linked to amyloidosis.